Cardinal Health (FRA:CLH) Inventories, Raw Materials & Components: €0 Mil (As of Mar. 2026)


FRA:CLH Cardinal Health Inc FRA:CLH
81 GF Score
Price €203.00
GF Value €120.72
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cardinal Health Inventories, Raw Materials & Components?

Cardinal Health FRA:CLH -0.68% 81 Inventories, Raw Materials & Components is €0 Mil as of Mar. 2026. GuruFocus rates FRA:CLH with a GF Score™ of 81/100 and a GF Value™ of €120.72 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Cardinal Health's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €0 Mil.

Cardinal Health Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Cardinal Health's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardinal Health Inventories, Raw Materials & Components Chart

Cardinal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cardinal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:CLH
81GF Score
Cardinal Health Inc FRA:CLH
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cardinal Health Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €0 Mil mean?
Cardinal Health (FRA:CLH) has a Inventories, Raw Materials & Components of €0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Cardinal Health and its competitors.
Is Cardinal Health's Inventories, Raw Materials & Components too high?
Cardinal Health's current Inventories, Raw Materials & Components is €0 Mil. Overall, Cardinal Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's Inventories, Raw Materials & Components compare to COR and MCK?
Cardinal Health's Inventories, Raw Materials & Components of €0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Distribution company?
A good Inventories, Raw Materials & Components depends on the Medical Distribution industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Cardinal Health and its competitors. Cardinal Health's current Inventories, Raw Materials & Components is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (FRA:CLH) is currently considered Significantly Overvalued. The stock's GF Value™ is €120.72, compared to a current price of €203.00 — trading 68.2% above its estimated fair value. The current Inventories, Raw Materials & Components is €0 Mil. Cardinal Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Cardinal Health (FRA:CLH), the current Inventories, Raw Materials & Components is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cardinal Health (FRA:CLH) Overvalued in 2026?

Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued. The current stock price of €203.00 is trading 68.2% above its estimated GF Value™ of €120.72. GuruFocus considers Cardinal Health to be Significantly Overvalued.

Key valuation signals for FRA:CLH:

  • Inventories, Raw Materials & Components: €0 Mil
  • GF Value™: €120.72 vs. price of €203.00 (68.2% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the FRA:CLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cardinal Health Business Description

Address 7000 Cardinal Place, Dublin, OH, USA, 43017
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
81GF Score

Get the complete analysis for FRA:CLH

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€203.00
Price
€120.72
GF Value